Symphion, Inc. Announces Print Fleet Security Certificate Deployment and Management Service™ to Close a Critical Gap in Enterprise and Healthcare Networks
DALLAS, Jan. 26, 2026 /PRNewswire/ — Symphion, Inc., the world leader in print fleet cyber security, today announces the launch of Print Fleet Security Certificate... Read more.
Sidus Space and Maris‑Tech Achieve Integration Milestone for LizzieSat‑4 Mission
Maris‑Tech payload to fly aboard LizzieSat‑4 as hardware testing and platform integration commence ahead of planned launch later this year CAPE CANAVERAL, Fla.,... Read more.
XTI Aerospace Drone Nerds Expands into Wearable Augmented Reality Technology with XREAL AR Glasses
Innovative AR Lineup Brings Immersive Experiences to Consumers and Enterprise Users ENGLEWOOD, Colo., Jan. 26, 2026 /PRNewswire/ — XTI Aerospace, Inc. (Nasdaq:... Read more.
Eightco ($ORBS) and Futurum Group Announce Strategic Partnership to Launch Futurum ORBS Trust and Authentication Platform (FOTAP)
Companies announce the industry’s first AI Trust & Authentication scoring system Partnership combines ORBS’ authentication infrastructure with Futurum’s... Read more.
Commvault Expands Collaboration with Google Cloud to Help Strengthen Enterprise Protection and Cyber Resilience
Commvault offers immutable, air-gapped protection, application “rewind” capabilities, and new data search capabilities that support compliance initiatives... Read more.
Immusoft Receives FDA Rare Pediatric Disease Designation for ISP-002 to treat Mucopolysaccharidosis Type II
Designation recognizes ISP-002, an engineered B cell therapy designed for sustained enzyme delivery SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ — Immusoft of... Read more.
Eastern International Ltd. Won the Bid for Its First Wind Power Construction Project Worth RMB 91.52 Million (Approx. USD 13.02 Million), Officially Marking Its Entry into the Wind Power Construction Sector
HANGZHOU, China, Jan. 26, 2026 /PRNewswire/ — Eastern International Ltd. (“Eastern International” or the “Company”) (NASDAQ: ELOG),... Read more.
Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1065890 in Adults with Tardive Dyskinesia
SAN DIEGO, Jan. 26, 2026 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of its Phase 2 clinical study of investigational... Read more.
Avant Technologies Evaluating Advanced Cells for Diabetes Therapy at 15th Annual EPITA Symposium
LAS VEGAS, Jan. 26, 2026 /PRNewswire/ — Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology... Read more.
RMX Attends Plug and Play Innovation Triangle Aerospace & Defense Expo, Spotlighting a New “Prove-It & Deliver-Fast” Era for Defense Innovation
DALLAS, Jan. 26, 2026 /PRNewswire/ — RMX Industries, Inc. (“RMX”) (OTCQB: RMXI) today announced it attended the Plug and Play Innovation Triangle... Read more.